Name & Description
The medicine is called: RALTEGRAVIR
Medicine manufacturer: HETRO
Medicine category: Uncategorised
Medicine packing type: STRIP of 60TAB
Medicine ACTUAL MRP: Rs. 8689
Medicine discounted price: Rs. 6890
Discount in %: 20.70%
Active Ingredients
RALTEGRAVIR contains the active ingredient Raltegravir.
Pharmacological Properties
RALTEGRAVIR belongs to a class of medications called integrase inhibitors. It works by blocking the action of an enzyme called integrase, which is necessary for the virus to multiply. This helps to prevent the HIV virus from spreading in the body.
Indications
RALTEGRAVIR is indicated for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 40 kg.
Contraindications
RALTEGRAVIR is contraindicated in patients with known hypersensitivity to raltegravir or any component of the formulation.
Dosage
The recommended dosage of RALTEGRAVIR for adults and pediatric patients weighing at least 40 kg is 400 mg taken orally twice daily.
Side Effects
Common side effects of RALTEGRAVIR may include headache, nausea, diarrhea, and fatigue. Contact your healthcare provider if you experience severe or persistent side effects.
Drug Interactions
RALTEGRAVIR may interact with other medications, including rifampin, antacids, and certain antifungal agents. Inform your healthcare provider about all the medications you are taking before starting RALTEGRAVIR.
Patient Counseling
Patient counseling is essential for individuals prescribed RALTEGRAVIR. Patients should be educated on the importance of adherence to the prescribed dosage regimen and the potential side effects of the medication. Additionally, patients should be advised to report any unusual symptoms or side effects to their healthcare provider.
Clinical Evidence
Clinical studies have demonstrated the efficacy and safety of RALTEGRAVIR in the treatment of HIV-1 infection. Consult your healthcare provider for more information on the clinical evidence supporting the use of RALTEGRAVIR.
Frequently Asked Questions
1. What is the active ingredient in RALTEGRAVIR?
The active ingredient in RALTEGRAVIR is Raltegravir.
2. What are the common side effects of RALTEGRAVIR?
Common side effects of RALTEGRAVIR may include headache, nausea, diarrhea, and fatigue.
3. How should RALTEGRAVIR be taken?
The recommended dosage of RALTEGRAVIR for adults and pediatric patients weighing at least 40 kg is 400 mg taken orally twice daily.
4. Are there any drug interactions with RALTEGRAVIR?
RALTEGRAVIR may interact with other medications, including rifampin, antacids, and certain antifungal agents. Inform your healthcare provider about all the medications you are taking before starting RALTEGRAVIR.
5. Can RALTEGRAVIR be used in pediatric patients?
RALTEGRAVIR is indicated for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 40 kg.
This detailed information about RALTEGRAVIR aims to provide a comprehensive overview of the medication, including its active ingredients, pharmacological properties, indications, contraindications, dosage, side effects, drug interactions, patient counseling, clinical evidence, and frequently asked questions. If you have further inquiries or require additional details, please consult your healthcare provider.
